SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Pharmachem informs about appointment of CS cum CO

18 Jan 2025 Evaluate
Pursuant to Regulation 30 and other applicable provisions of the Listing Regulations, Omkar Pharmachem has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held today Saturday, January 18th, 2025, approved the appointment of Pankaj Mahadeo Singh as Company Secretary (CS) and Compliance Officer (CS) with effect from January 18th, 2025. The required details pursuant to SEBI Listing Regulations are provided in the Annexure to this letter.

The above information is a part of company’s filings submitted to BSE.

Omkar Pharmachem Share Price

28.03 0.00 (0.00%)
27-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.75
Dr. Reddys Lab 1297.05
Cipla 1322.20
Zydus Lifesciences 901.50
Lupin 2344.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×